Mostrando 3 resultados de: 3
Filtros aplicados
Área temáticas
Enfermedades(2)
Medicina forense; incidencia de enfermedades(2)
Medicina y salud(2)
Farmacología y terapéutica(1)
Otros problemas y servicios sociales(1)
Objetivos de Desarrollo Sostenible
ODS 10: Reducción de las desigualdades(3)
ODS 17: Alianzas para lograr los objetivos(3)
ODS 3: Salud y bienestar(3)
Author Correction: Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals (Nature Medicine, (2022), 28, 7, (1476-1485), 10.1038/s41591-022-01807-1)
OtherAbstract: In the version of this article initially published, there was an error in the spelling of Raphael SoPalabras claves:Autores:Aguiar R.S., Araujo L.J.T., Bastos L.S., Bernardo M. Gutierrez, Bhatt S., Blenkinsop A., Bonfim D.M., Brizzi A., Buss L.F., Castro M.C., Costa S.F., Croda J., da Silva Candido D., de Souza W.M., de Souza-Santos A.A., Dye C., Faria N.R., Flaxman S., Fonseca P.L.C., Geddes V.E.V., Hawryluk I., Lemey P., Levin A.S., Mellan T., Miscouridou X., Mishra S., Monod M., Moreira F.R.R., Nelson B.W., Pereira R.H.M., Prete C.A., Ranzani O.T., Ratmann O., Sabino E.C., Schnekenberg R.P., Semenova E., Servo L.M.S., Sonabend R., Souza R.P., Whittaker C., Xi X.Fuentes:scopusStudy protocol for the multicentre cohorts of Zika virus infection in pregnant women, infants, and acute clinical cases in Latin America and the Caribbean: The ZIKAlliance consortium
ArticleAbstract: Background: The European Commission (EC) Horizon 2020 (H2020)-funded ZIKAlliance Consortium designedPalabras claves:arboviruses, Caribbean, CHILDREN, cohort, congenital abnormalities, Latin America, Mosquito-borne viruses, Natural History, pregnant women, Risk, Vector-borne viruses, zikaAutores:Alexander N., Allison H.G., Alpuche-Aranda C., Álvarez S.S., Arrata M.R., Arriaga L., Avelino-Silva V.I., Bethencourt S., Bonaldo M., Borja-Aburto V.H., Brasil P., Carmen Soria-Segarra, Damasceno L., De Filippis A.M.B., De Lamballerie X., De Melo Espíndola O., Dimitrakis L., Dorticós D.F., Duarte A.C.M., Falcon C., Gelvez R.M., Gomez A., Gonzalez C., González-Diaz E., Gotuzzo H J.E., Grajales C., Guzman M.G., Hegewisch-Taylor J., Herrera V.M., Hoen B., Jaenisch T., Jänisch T., Koopmans M., La Rosa Y., Leege A., Lins R.D., Lopez-Gatell H., Lozano A., Marques E.T.A., Martínez P.A., Martínez Rodríguez P.A., Matos V., Mayaud P., Mendes-Correa M.C., Miranda M.C., Morales I., Murillo M., Nacul L., Netto E.M., Ortiz R., Pavía-Ruz N., Pohl M., Rabello R., Reyes A., Rockx B., Rodríguez E., Rojas T., Rosenberger K.D., Saba Villarroel P.M., Sabino E.C., Salgado S.P., Santana B.G., Schretzmann J., Segurado A., Soria C., Talledo M., Tami A., Thirion L., Tinedo M.J., Tobian F., Torres E.M., Tynevez D., Uhlmann L., Vallejos A., Vera M.A., Viana I.F.T., Villar L.A., Villarroel P.M.S.Fuentes:scopusUnderstanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: A Modelling Analysis
ArticleAbstract: Background. The public health impact of the coronavirus disease 2019 (COVID-19) pandemic has motivatPalabras claves:covid-19, epidemiology, modelling, SARS-COV-2, therapeuticsAutores:Alvarez-Moreno C.A., Angkasekwinai N., Boonyasiri A., Chanda D., Charoenpong L., Chayakulkeeree M., Cooke G.S., Costa S.F., Croda J., Cucunubá Z.M., Djaafara B.A., Esteban Ortiz-Prado, Estofolete C.F., Faria N.R., Forero-Peña D.A., Ghani A.C., Gibb D.M., Gordon A.C., Grillet M.E., Hallett T.B., Hamers R.L., Hamlet A., Irawany V., Jitmuang A., Keurueangkul N., Kimani T.N., Lampo M., Levin A.S., Lopardo G., Mustafa R., Nayagam S., Ngamprasertchai T., Njeri N.I.H., Nogueira M.L., Perroud M.W., Phillips A.N., Promsin P., Qavi A., Rodger A.J., Sabino E.C., Sangkaew S., Sari D., Sirijatuphat R., Sposito A.C., Srisangthong P., Thompson H.A., Triana L.C., Udwadia Z.F., Valderrama-Beltrán S.L., Walker P.G.T., Watson O.J., Whittaker C., Winskill P.Fuentes:googlescopus